Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News


Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 


06/21/2013 | 05:03am US/Eastern

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.


PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.


Jane Baj

PTC Therapeutics, Inc.



Sheryl Seapy

Pure Communications


distributed by
React to this article
Latest news
Date Title
09:14p AMETEK : School closed for testing decades after chemical leak
09:13p MITSUBISHI ELECTRIC : to Expand Lineup of Tough Series TFT-LCD Modules
09:10p FRESH MARKET : Review of dash cam footage raises questions about Germantown officer's account
09:09pDJAsian Shares Fall; Commodities Recovery Lifts Resource Shares--Update
09:08p KOBE STEEL : The new publication of KOBELCO WELDING TODAY was up-loaded.
09:08p HITACHI HIGH TECHNOLOGIES : Announcement of New CS4800 Advanced High Resolution CD-SEM
09:08p AUROCH MINERALS NL : Results of Meeting
09:07p FEDEX : BRIEF: French terrorist probe extends to FedEx hub in Paris
09:07p FEDEX : BRIEF: Feds approve FedEx buyout of Dutch rival TNT
09:06pDJFDA PANEL : BioMarin Muscular Dystrophy Not Effective
Latest news
Hot News 
HARBOURVEST HVGPE : New Board Committees
TANGENT COMMUNICATIONS : Sees Pretax Profit Fall Amid Muted Sales Growth
RECORD : Reports Fall In Interim Profit As Revenue Edges Up
IMMUNODIAGNOSTIC SYSTEMS HLDGS : Warns Revenue To Fall As Conditions Still Challenging
BOULDER BRANDS : Pinnacle buying Boulder Brands for about $710 million
Most Read News
06:24p PARK PLACE ENERGY : Stockholders Approve Reincorporation in Delaware
08:25p Hastings’ Managed Utilities Trust of Australia Named as a Successful Bidder for TransGrid
07:25pDJSingapore 3Q GDP Growth Revised Up Sharply
06:40p IDAHO PUBLIC UTILITIES COMMISSION : Avista proposes resumption of natural gas efficiency programs
08:21p PROTASCO BHD : Interim Dividend
Most recommended articles
09:09pDJAsian Shares Fall; Commodities Recovery Lifts Resource Shares--Update
09:06pDJFDA PANEL : BioMarin Muscular Dystrophy Not Effective
09:06pDJCostco's Rotisserie Chicken Salad Linked to E. Coli Outbreak
09:06pDJAsian Shares Fall; Higher Oil Lifts Energy Shares
09:06pDJFed Promises to Improve Process for Airing 'Divergent Views'